Entry Point Capital, LLC Harmony Biosciences Holdings, Inc. Transaction History
Entry Point Capital, LLC
- $221 Million
- Q4 2024
A detailed history of Entry Point Capital, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 32,084 shares of HRMY stock, worth $1.25 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
32,084Holding current value
$1.25 Million% of portfolio
0.5%Shares
4 transactions
Others Institutions Holding HRMY
# of Institutions
249Shares Held
47.5MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL6.62MShares$259 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$228 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$185 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$89.1 Million0.19% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.45MShares$56.7 Million2.2% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.31B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...